Loading...
Hepion Pharmaceuticals, Inc.
HEPA•NASDAQ
Healthcare
Biotechnology
$0.09
$0.001(0.57%)
Hepion Pharmaceuticals, Inc. (HEPA) Financial Performance & Statements
Review Hepion Pharmaceuticals, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
60.07%
↑ 60.07%
Net Income Growth
73.04%
↑ 73.04%
Operating Cash Flow Growth
55.45%
↑ 55.45%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-598.75%
↓ 598.75%
ROIC
1264.36%
↑ 1264.36%
Hepion Pharmaceuticals, Inc. (HEPA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Hepion Pharmaceuticals, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $30758.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$30758.00 |
| Gross Profit Ratio | $0.00 | $0.00 | ||
| R&D Expenses | -$591608.00 | $2.76M | $7.14M | $2.54M |
| SG&A Expenses | $1.79M | $1.70M | $1.37M | $2.61M |
| Operating Expenses | $1.20M | $4.46M | $8.50M | $5.15M |
| Total Costs & Expenses | $1.20M | $4.46M | $8.50M | $5.18M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $4349.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $30758.00 |
| EBITDA | $3.23M | -$4.46M | -$8.50M | -$5.79M |
| EBITDA Ratio | ||||
| Operating Income | -$1.20M | -$4.46M | -$8.50M | -$5.18M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$345300.00 | -$407689.00 | $4.58M | -$640741.00 |
| Income Before Tax | -$1.55M | -$4.87M | -$3.93M | -$5.82M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$2.97M |
| Net Income | -$1.55M | -$4.87M | -$3.93M | -$2.85M |
| Net Income Ratio | ||||
| EPS | -$12.59 | -$36.21 | -$33.84 | -$28.13 |
| Diluted EPS | -$12.59 | -$36.21 | -$33.84 | -$28.13 |
| Weighted Avg Shares Outstanding | $139168.00 | $134000.00 | $115000.00 | $101000.00 |
| Weighted Avg Shares Outstanding (Diluted) | $139168.00 | $134379.00 | $115983.00 | $101450.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan